Shazia K. Nakhoda, MD

Assistant Professor, Department of Hematology/Oncology

Hematology-Lymphoma Program

Specialties

Hematology Oncology

Areas of Expertise

Myeloma, Lymphoma, Leukemia

Treatment Focus

Malignant Hematology; Central Nervous System Lymphoma

Distinctions

Treatment Philosophy

Navigating a new cancer diagnosis can be challenging and overwhelming. I feel honored to be part of a team that provides patients and their families not only specialized oncologic care, but also the support and resources needed. The collaborative network of clinicians, nurses, and researchers at Fox Chase allows me to provide my patients individualized treatment options, novel therapies, and access to clinical trials. In addition, I strive to provide my patients and their families compassionate and comprehensive clinical care throughout each aspect of their journey.

Clinical Locations

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427

Educational Background

Hematology & Oncology Fellowship Training, Temple University and Fox Chase Cancer Center, Philadelphia, PA, 07/2017-06/2020
Internal Medicine Residency Training, University of Maryland Medical Center, Baltimore, MD, 6/2014-06/2017
MD, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, 2014

Certifications

American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Medical Oncology

Memberships

American Society of Clinical Oncology
American Society of Hematology

Honors & Awards

Philadelphia Magazine Top Doctors, 2024
Awarded Honorable Mention for the Arnold R. Weitz, M.D. Memorial Prize in Hematology, 2014

Selected Publications

Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies. Nakhoda SK, Olszanski AJ. Pharmaceut Med. 2020 Apr;34(2):83-91. doi: 10.1007/s40290-020-00326-z. PMID: 32157638

Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Nakhoda S, Zimrin AB, Baer MR, Law JY. Transfus Apher Sci. 2017 Apr;56(2):123-126. doi: 10.1016/j.transci.2016.10.005. Epub 2016 Oct 17. PMID: 27789124 Clinical Trial.

Additional Publications

MyNCBI

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Overall Care

5.0

Explained Things Clearly

5.0

Showed Courtesy & Respect

5.0

Discussed Treatment Options

5.0

Recommend Provider

5.0

Patient comments

5 out of 5 (202 ratings, 48 comments)

03/10/2025

She was excellent.

03/10/2025

Dr. Nakhoda is an exceptional oncologist who brings both expertise and compassion to patient care. Patients appreciate her thorough approach, taking the time to explain treatment options clearly while ensuring they feel heard and supported. Her Dedication to personalized care helps ease the stress of a cancer diagnosis, making a difficult journey more manageable. Her kindness, knowledge, and commitment to her patients make her a trusted and respected physician. Anyone under her care is in excellent hands.

03/10/2025

[...] Thank you for listening!

02/26/2025

Dr. Nakhoda is very professional, knowledgeable and compassionate doctor, being under her care I have this feeling that I am in " good hands" and I trust her recommendations completely.